Metabolomics Market worth $2,100 Million by 2019 - WDAM.COM - TV 7 - News, Weather and Sports

Metabolomics Market worth $2,100 Million by 2019

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE MarketsandMarkets

DALLAS, June 26, 2014 /PRNewswire/ --

The report "Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry, by Application (Biomarker & Drug Discovery, Nutrigenomics), by Indication (Oncology, Cardiology) - Global Forecast to 2019" published by MarketsandMarkets, analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.

Browse 80 market data tables and 7 figures spread through 270 Slides and in-depth TOC on "Metabolomics Market- Global Forecast to 2019"

http://www.marketsandmarkets.com/Market-Reports/metabolomics-technology-market-900.html

Early buyers will receive 10% customization on this report. 

This report studies the metabolomics market over the forecast period of 2014 to 2019.

The technological progress in biochemistry and molecular biology has played a significant role in the development of the metabolomics market during the last decade. Also, the improvements in analytical instruments, and data processing and analysis software have contributed significantly in the advancement of the metabolomics field. The presence of research funding and government support for conducting research and commercialization of the products in the metabolomics market is the primary driver for the growth of this market. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the Metabolomics Market. However, the lack of skilled professionals in metabolomics science is a significant restraint for the growth of the metabolomics market. The low adoption rates of metabolomics and data complexity are the other factors that are hindering the growth of the metabolomics market.

In this report, the Metabolomics Market is segmented based on techniques, applications, indications, geographic regions, and countries. This report also discusses the key market drivers, restraints, and opportunities for this market and its sub-markets. The global Metabolomics Market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

Inquiry before buying @  http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=900 

In 2013, North America was the market leader with a share of 42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European Metabolomics Market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).

 Browse related reports 

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018

http://www.marketsandmarkets.com/Market-Reports/gene-expression-analysis-market-156613968.html

About MarketsandMarkets  

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, healthcare IT semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com


©2012 PR Newswire. All Rights Reserved.